ITGAM and non-small cell lung carcinoma: According to multiplex quantitative immunofluorescence staining of non-small cell lung cancer (NSCLC) tissues, the proportion of CD11b + /HLA-DR − MDSCs-like cells was found to be dramatically more abundant in the tumor than in the matched non-tumor lung tissue, and increased expression of CD11b or HLA-DR was linked to a trend toward shorter 5-year survival [21].